| Thursday, September 12, 2024 | ||||
|---|---|---|---|---|
| 8:00 AM - 8:29 AM | Employer Arrival and Breakfast | |||
| 8:30 AM - 9:29 AM | Roundtable (Employers Only) | A focused discussion for decision makers, addressing key topics in pharmacy benefits management. Topics include cost containment, employee wellness, and emerging trends in pharmaceuticals. | Jared Lewis, Curtiss-Wright Corp. | |
| 9:30 AM - 9:59 AM | General Arrival and Breakfast | |||
| 10:00 AM - 10:04 AM | Welcome | Kim Thiboldeaux, NEBGH | ||
| 10:05 AM - 10:34 AM | Pharmacy Benefits Market Overview | The current landscape of the pharmaceutical Industry: Key legislation, PBM reform, market disrupters and more! | Josh Golden, Capital Rx | |
| 10:35 AM - 10:49 AM | Morning Break | |||
| 10:50 AM - 11:29 AM | GLP-1s and Workplace Health: Balancing Costs and Benefits | GLP-1s: Medication evolution, trends in utilization, and what employers should be doing now. | Charles E. Smith, MD, Aon Health Solutions Florencia Halperin, MD, Form Health Matthew Houser, RPh, MBA, Cigna Pharmacy Jeanne Walsh, Boston Scientific | |
| 11:30 AM - 11:44 AM | RxIgnite Talk – Prescription Digital Therapy | 15-minute, short, and powerful presentations that ignite inspiration, innovation, and action. | Andrew Heller, Boehringer Ingelheim | |
| 11:45 AM - 12:24 PM | Aligning Benefit Plans with Cancer Care Evolution | Benefits professionals ensure plans adapt to cancer care’s changes, including immunotherapy. Understanding these points aids employee support in cancer journeys. | Prachi Nagda, MD, Mercer Dennis Flannelly, Merck Nicki MacManus, Employer Direct Healthcare Jennifer Carter, MD, MPH, Medzown, Inc. Mike Quigg, MS, Color Health | |
| 12:25 PM - 1:14 PM | Networking Lunch and Sponsor Exhibits | |||
| 1:15 PM - 1:44 PM | Taming Specialty Drug Costs for Employers | Explore cost-saving tactics for benefit plans, including transparency, PBMs, and compliance. Gain insights on formulary management, data analytics, and employee education. | Tara Higgins, PharmD, PSG | |
| 1:45 PM - 1:59 PM | Afternoon Break | |||
| 2:00 PM - 2:59 PM | Insights and Discussion: Integrating Gene and Cell Therapy into Employee Benefit Plans | Employers balancing gene therapy’s high costs and reputational risks against their potential to cure untreatable diseases must strategically assess benefits and drawbacks for informed benefits decisions. | Eileen Pincay, RPh, Segal New York Mark Godwin, PharmD, AAHIVE, UnitedHealthcare Ashley Hume, Emerging Therapy Solutions | |
| 3:00 PM | Adjourn | |||
